Rang	Name	Position
1	Ms. Lucinda Warren	Principal Accounting Officer & Chief Business Officer
2	Mr. Colin G. Sandercock J.D., MSE	Senior Vice President of Intellectual Property
3	Dr. Shao-Lee Lin M.D., Ph.D.	President, CEO & Director
4	Dr. Ronald D. Seidel III, Ph.D.	Co-Founder
5	Dr. Rodolfo Jose Chaparro Ph.D.	Co-Founder
6	Dr. Steven C. Almo Ph.D.	Co-Founder and Chairman of Scientific & Clinical Advisory Board
7	Mr. James M. Ahlers	Chief Financial Officer
8	Ms. Agnes Lee	Chief Officer of Public & Investor Relations
9	Ms. Sumita Ray J.D.	Chief Legal & Compliance Officer and Corporate Secretary
10	Dr. Daniel G. Baker M.D., Ph.D.	Interim Chief Development Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Bleichroeder LP	3,13%	6,53 Mio. USD
2	Vanguard Capital Management, LLC	1,13%	2,35 Mio. USD
3	Geode Capital Management, LLC	0,49%	1,02 Mio. USD
4	Vanguard Fiduciary Trust Co	0,25%	0,52 Mio. USD
5	BlackRock Inc	0,21%	0,43 Mio. USD
6	Stifel Financial Corp	0,11%	0,24 Mio. USD
7	Renaissance Technologies Corp	0,10%	0,21 Mio. USD
8	Bank of America Corp	0,10%	0,20 Mio. USD
9	State Street Corp	0,08%	0,17 Mio. USD
10	Northern Trust Corp	0,04%	0,09 Mio. USD
11	Polygon Management Ltd	1,29%	2,70 Mio. USD
12	UBS Group AG	0,04%	0,09 Mio. USD
13	Northwestern Mutual Wealth Management Co	0,04%	0,08 Mio. USD
14	Lion Point Capital, LP	0,73%	1,52 Mio. USD
15	Squadron Capital Management LLC	0,69%	1,44 Mio. USD
16	Virtu Financial LLC	0,02%	0,05 Mio. USD
17	Diadema Partners LP	0,67%	1,39 Mio. USD
18	The Goldman Sachs Group Inc	0,02%	0,03 Mio. USD
19	Persistent Asset Partners Limited	0,02%	0,03 Mio. USD
20	Visionary Wealth Advisors	0,01%	0,03 Mio. USD